Welcome to our dedicated page for ENvue Medical news (Ticker: FEED), a resource for investors and traders seeking the latest updates and insights on ENvue Medical stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ENvue Medical's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ENvue Medical's position in the market.
ENvue Medical (NASDAQ: ENVB) announced on December 15, 2025 that David Johnson has been appointed Chairman of the Board. Johnson brings more than 30 years of healthcare leadership and board experience, including roles guiding Advanced Medical Balloons through acquisition and prior executive positions at ConvaTec and others.
The company said its 510(k) FDA-cleared feeding-tube placement system is in clinical use across 38 US hospitals, and management plans to increase hospital adoption in 2026 while pursuing additional 510(k) clearances to expand into neonatal and pediatric markets.
FAQ
What is the current stock price of ENvue Medical (FEED)?
What is the market cap of ENvue Medical (FEED)?
